Wayland Selected as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany

April 04, 19

TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is excited to announce that the Company has been selected by the German Federal Institute for Drugs and Medical Devices (“BfArM”), through its German joint venture DEMECAN GmbH, to begin domestic production of medical cannabis for the rapidly

Read More

Wayland Group Announces Facility Drawdown

March 23, 19

TORONTO, March 22, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the third facility under its previously-announced subscription agreement with Alpha Blue and has issued the corresponding Convertible Debenture and Facility Warrants. Please refer to the Company’s news release of

Read More

Wayland Group Announces Facility Drawdown

March 15, 19

TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the second facility under its previously-announced subscription agreement with Alpha Blue and issued the corresponding Convertible Debenture and Facility Warrants. Please refer to the Company’s news release of February

Read More

Wayland Group announces Corporate Update

March 11, 19

TORONTO, March 11, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce it is near completion of its due diligence of International Cannabis Corp (ICC). Wayland group is pleased to announce it is near completion of its due diligence of International Cannabis Corp. (ICC) and is

Read More

Wayland Group Provides Corporate Update

February 20, 19

TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce a corporate update on its operational progress in Canada and internationally. Langton Production Facilities The Company is now completing a third harvest at its new facility in Langton, ON, Canada, with licenses for cultivation

Read More

Wayland Group Receives EU-GMP Certification for German Facility

February 07, 19

TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that it has received both Good Manufacturing Practices and Good Distribution Practices certifications from the national authority in the State of Saxony for the Company’s Ebersbach facility in Germany. Specifically, these certifications are for a

Read More

Wayland Group Enters into a Letter to Sell 49.9% of International Business to International Cannabis Corp.

January 15, 19

TORONTO, ON, January 15, 2019 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that, pursuant to the Company’s previously announced strategic review, it has entered into a Letter (“Letter”) to sell 49.9% of the Company’s international portfolio of assets to International Cannabis Corp (“ICC”). Wayland will receive 300,000,000

Read More

Wayland Enters the Asia-Pacific Market with Australian Acquisition

December 03, 18

TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce its expansion into Australia, through entering into an agreement to acquire 50.1% of Tropicann Pty Ltd. (“Tropicann”), a newly formed, privately owned Australian company located in Darwin, Northern Territory, to partner with industry leaders

Read More

Wayland Group Enters the United Kingdom

November 26, 18

TORONTO, ON, November 26, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd. ("Theros"), an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical

Read More

Wayland Group Announces Appointment of General Counsel

November 19, 18

TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce the appointment of Matthew McLeod who will assume the role of General Counsel. The Company is pleased to welcome Matthew to the newly created role. Mr. McLeod was called to the Ontario bar in

Read More